Granules' net zero commitment approved by SBTi
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
Modernization and supply chain diversity drive new growth
Tyvek with Renewable Attribution is designed to help reduce the carbon footprint
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency
Silica is a proven and highly effective anti-caking agent that has been used for decades
Buckley served as Chairman and Chief Executive Officer at Vanguard from 2018 until his retirement in 2024
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
The net-zero target approval complements the company's near-term emission reduction targets
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
Subscribe To Our Newsletter & Stay Updated